ER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cells.

Glioblastoma is a highly heterogeneous aggressive primary brain tumor, with the glioma stem-like cells (GSC) being more sensitive to cytotoxic lymphocyte-mediated killing than glioma differentiated cells (GDC). However, the mechanism behind this higher sensitivity is unclear. Here, we found that the mitochondrial morphology of GSCs modulates the ER-mitochondria contacts that regulate the surface expression of sialylated glycans and their recognition by cytotoxic T lymphocytes and natural killer cells. GSCs displayed diminished ER-mitochondria contacts compared to GDCs. Forced ER-mitochondria contacts in GSCs increased their cell surface expression of sialylated glycans and reduced their susceptibility to cytotoxic lymphocytes. Therefore, mitochondrial morphology and dynamism dictate the ER-mitochondria contacts in order to regulate the surface expression of certain glycans and thus play a role in GSC recognition and elimination by immune effector cells. Targeting the mitochondrial morphology, dynamism, and contacts with the ER could be an innovative strategy to deplete the cancer stem cell compartment to successfully treat glioblastoma.

Amyloid-beta oligomerization is associated with the generation of a typical peptide fragment fingerprint.

Amyloid-beta (Aß) peptide oligomerization plays a central role in the pathogenesis of Alzheimer's disease (AD), and Aß oligomers are collectively considered an appealing therapeutic target for the treatment of AD. However, the molecular mechanisms leading to the pathologic accumulation of oligomers are unclear, and the exact structural composition of oligomers is being debated. Using targeted and quantitative mass spectrometry, we reveal site-specific Aß autocleavage during the early phase of aggregation, producing a typical Aß fragment signature and that truncated Aß peptides can form stable oligomeric complexes with full-length Aß peptide. We show that the use of novel anti-Aß antibodies raised against these truncated Aß isoforms allows for monitoring and targeting the accumulation of truncated Aß fragments. Antibody-enabled screening of transgenic models of AD as well as human postmortem brain tissue and cerebrospinal fluid revealed that aggregation-associated Aß cleavage is a highly relevant clinical feature of AD.

Bioengineering of dental tissues: bibliometric analysis 2000-2011 / Bioingeniería de tejidos dentales: análisis bibliométrico 2000-2011

Introduction: There has been a noticeable increase in experimental use and therapies based on stem cells over recent years. Nevertheless, there is a lack of information about this progress in the dental field, which makes it difficult to trace development and design policies. The purpose of this study, as a first approach to the subject, is to determine a bibliometric profile for the investigation related to bioengineering of dental tissue at a worldwide scale, based on the MEDLINE database, for the period 2000-2011.Methodology: A bibliometric study was carried out. Every article indexed in the MEDLINE database and associated with the terms “stem cells” and “tooth regeneration” for the period 2000-2011 was included. The analyzed variables were publishing date, country of origin, language and publication type (original or review), journal, author, associated university and tissue source (human or animal). Results: For the entire period included in the study, 257 articles were found. Of these, 149 corresponded to original works published in English; 5 in other languages; 92 comprised literature reviews in English, 9 in other languages and 2 publications were included in the “others” category. The countries with the highest research productivity were the United States (24.51 percent, Japan (20.62 percent) and China (17.90 percent), while Brazil (3.9 percent) was the only Latin-American country found in the list. Animal tissues were used in 59.09 percent of them. The most productive authors were Ueda M (17) and Jin Y (11), whereas Fourth Military University (13), University of Tokyo (12) and Capital Medical University (10) had the largest number of publications. Conclusion: The United States, Japan and China concentrate about two thirds of the production. Latin-America was represented only by Brazil.

Introducción: El creciente uso experimental de células madres y el perfeccionamiento de las terapias con estas es un hecho notorio en los últimos años. Sin embargo, en odontología no existen datos del desarrollo de esta área, lo que hace difícil un seguimiento o diseño de políticas. El objetivo de este estudio, siendo una primera aproximación a la temática, es definir el perfil bibliométrico de la investigación asociada a la bioingeniería de tejidos dentales a nivel mundial en la base de datos MEDLINE para el periodo 2000-2011. Metodología: Estudio bibliométrico. Se incluyeron todos los artículos asociados a los términos “stem cells” y “tooth regeneration” para el periodo 2000-2011, indexadas en MEDLINE. Se analizaron las variables: año de publicación, país de origen, idioma y tipo de publicación (original o revisión), revista, autor, universidad de afiliación y origen del tejido utilizado (humano o animal). Resultados: Para todo el período en estudio se hallaron 257 artículos: 149 trabajos de originales publicados en inglés, 5 en otros idiomas; 92 revisiones de literatura en inglés y 9 en otros idiomas; y 2 publicaciones en categoría otros. Los países más productivos fueron Estados Unidos (24,51 por ciento), Japón (20,62 por ciento), China (17,90 por ciento), el único latinoamericano es Brasil (3,9 por ciento). El 59,09 por ciento utilizó tejidos de origen animal. Los autores más productivos fueron Ueda M (17) y Jin Y (11), en universidades fueron Fourth Military University (13), University of Tokyo (12) y Capital Medical University (10). Conclusión: Estados Unidos, Japón y China concentran dos tercios de la producción, Brasil es el único representante latinoamericano.

A BAX/BAK and cyclophilin D-independent intrinsic apoptosis pathway.

Most intrinsic death signals converge into the activation of pro-apoptotic BCL-2 family members BAX and BAK at the mitochondria, resulting in the release of cytochrome c and apoptosome activation. Chronic endoplasmic reticulum (ER) stress leads to apoptosis through the upregulation of a subset of pro-apoptotic BH3-only proteins, activating BAX and BAK at the mitochondria. Here we provide evidence indicating that the full resistance of BAX and BAK double deficient (DKO) cells to ER stress is reverted by stimulation in combination with mild serum withdrawal. Cell death under these conditions was characterized by the appearance of classical apoptosis markers, caspase-9 activation, release of cytochrome c, and was inhibited by knocking down caspase-9, but insensitive to BCL-X(L) overexpression. Similarly, the resistance of BIM and PUMA double deficient cells to ER stress was reverted by mild serum withdrawal. Surprisingly, BAX/BAK-independent cell death did not require Cyclophilin D (CypD) expression, an important regulator of the mitochondrial permeability transition pore. Our results suggest the existence of an alternative intrinsic apoptosis pathway emerging from a cross talk between the ER and the mitochondria.

BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1α.

Adaptation to endoplasmic reticulum (ER) stress depends on the activation of the unfolded protein response (UPR) stress sensor inositol-requiring enzyme 1α (IRE1α), which functions as an endoribonuclease that splices the mRNA of the transcription factor XBP-1 (X-box-binding protein-1). Through a global proteomic approach we identified the BCL-2 family member PUMA as a novel IRE1α interactor. Immun oprecipitation experiments confirmed this interaction and further detected the association of IRE1α with BIM, another BH3-only protein. BIM and PUMA double-knockout cells failed to maintain sustained XBP-1 mRNA splicing after prolonged ER stress, resulting in early inactivation. Mutation in the BH3 domain of BIM abrogated the physical interaction with IRE1α, inhibiting its effects on XBP-1 mRNA splicing. Unexpectedly, this regulation required BCL-2 and was antagonized by BAD or the BH3 domain mimetic ABT-737. The modulation of IRE1α RNAse activity by BH3-only proteins was recapitulated in a cell-free system suggesting a direct regulation. Moreover, BH3-only proteins controlled XBP-1 mRNA splicing in vivo and affected the ER stress-regulated secretion of antibodies by primary B cells. We conclude that a subset of BCL-2 family members participates in a new UPR-regulatory network, thus assuming apoptosis-unrelated functions.

Axonal degeneration is mediated by the mitochondrial permeability transition pore.

Axonal degeneration is an active process that has been associated with neurodegenerative conditions triggered by mechanical, metabolic, infectious, toxic, hereditary and inflammatory stimuli. This degenerative process can cause permanent loss of function, so it represents a focus for neuroprotective strategies. Several signaling pathways are implicated in axonal degeneration, but identification of an integrative mechanism for this self-destructive process has remained elusive. Here, we show that rapid axonal degeneration triggered by distinct mechanical and toxic insults is dependent on the activation of the mitochondrial permeability transition pore (mPTP). Both pharmacological and genetic targeting of cyclophilin D, a functional component of the mPTP, protects severed axons and vincristine-treated neurons from axonal degeneration in ex vivo and in vitro mouse and rat model systems. These effects were observed in axons from both the peripheral and central nervous system. Our results suggest that the mPTP is a key effector of axonal degeneration, upon which several independent signaling pathways converge. Since axonal and synapse degeneration are increasingly considered early pathological events in neurodegeneration, our work identifies a potential target for therapeutic intervention in a wide variety of conditions that lead to loss of axons and subsequent functional impairment.

Alternative functions of the BCL-2 protein family at the endoplasmic reticulum.

Apoptosis is essential for maintenance of tissue homeostasis and its deregulation results in a variety of disease conditions. The BCL-2 family of proteins is a group of evolutionarily conserved regulators of cell death that comprises both anti- and pro-apoptotic members, that operate at the mitochondrial membrane to control caspase activation. Different BCL-2-related proteins are also located in the endoplasmic reticulum (ER), where important roles in organelle physiology are proposed. Adaptation to ER stress is mediated by the activation of a complex signal transduction pathway known as the unfolded protein response (UPR). Recent reports indicate that the ER stress sensor IRE1alpha, signals through the formation of a protein complex platform at the ER membrane, here termed the "UPRosome". Alternatively, BCL-2 family members are contained in other multiprotein complexes at the ER that are involved in the control of diverse cellular processes including calcium homeostasis, autophagy and ER morphogenesis. Here we describe the emerging concept that BCL-2 family members are important regulators of essential cellular processes beyond apoptosis.

BAX inhibitor-1 is a negative regulator of the ER stress sensor IRE1alpha.

Adaptation to endoplasmic reticulum (ER) stress depends on the activation of an integrated signal transduction pathway known as the unfolded protein response (UPR). Bax inhibitor-1 (BI-1) is an evolutionarily conserved ER-resident protein that suppresses cell death. Here we have investigated the role of BI-1 in the UPR. BI-1 expression suppressed IRE1alpha activity in fly and mouse models of ER stress. BI-1-deficient cells displayed hyperactivation of the ER stress sensor IRE1alpha, leading to increased levels of its downstream target X-box-binding protein-1 (XBP-1) and upregulation of UPR target genes. This phenotype was associated with the formation of a stable protein complex between BI-1 and IRE1alpha, decreasing its ribonuclease activity. Finally, BI-1 deficiency increased the secretory activity of primary B cells, a phenomenon regulated by XBP-1. Our results suggest a role for BI-1 in early adaptive responses against ER stress that contrasts with its known downstream function in apoptosis.